(2-chlorophenyl) acetate
|
812-487-4
|
4525-75-1
|
|
REACH registration C&L
|
View details
|
1,6-Naphthyridine-3-carboxylic acid
|
812-489-5
|
1017793-59-7
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
4-(Triphenylmethyl) Piperazine Succinate
|
943-399-5
|
|
Skin Sens. 1
Eye Irrit. 2
Repr. 2
|
Notified C&L
|
View details
|
Carbamic acid, N-[(1S)-3-methyl-1-[[(2S)-2-methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-dimethylethyl ester
|
812-494-2
|
247068-83-3
|
Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 3
|
Notified C&L
|
View details
|
4-Morpholineethanamine, N-(1,1-dimethylethyl)-
|
812-495-8
|
22687-32-7
|
Acute Tox. 4
Skin Corr. 1A
Eye Dam. 1
|
Notified C&L
|
View details
|
Phosphoric acid, C14-15 branched and linear alkyl esters, potassium salts
|
812-497-9
|
1893414-79-3
|
|
Notified C&L
|
View details
|
reaction products of diazotised 4-nitrobenzenamine, coupled with 6-amino-4-hydroxynaphthalene-2-sulfonic acid, subsequently diazotised and coupled with the reaction product of diazotized 3-amino-4-hydroxy-5-nitrobenzenesulfonic acid and resorcinol, sodium salt.
|
943-403-5
|
|
|
REACH registration C&L
|
View details
|
S-Alanine,N-3,5-difluoro-2-oxo-1-phenylethyl-R-alanyl-2phenyl-,1,1-dimethylethylester
|
943-405-6
|
|
|
Notified C&L
|
View details
|
C8-18 (even numbered) and C18 (unsaturated) sarcosinates, 2-hydroxypropylammonium salt
|
943-406-1
|
|
|
Notified C&L
|
View details
|
Bis(2-methyl-2-propanyl)(phenyl)phosphonium tetrafluoroborate
|
943-407-7
|
|
|
Notified C&L
|
View details
|
1,4-Bis(di-t-butylphosphonium)butane bis(tetrafluoroborate)
|
943-408-2
|
|
|
Notified C&L
|
View details
|
1,4-Bis(dicyclohexylphosphonium)butane bis(tetrafluoroborate)
|
943-409-8
|
|
|
Notified C&L
|
View details
|
1,2-Bis(dicyclohexylphosphonium)ethane bis(tetrafluoroborate)
|
943-410-3
|
|
|
Notified C&L
|
View details
|
(2'-Methylamino-1,1'-biphenyl-2-yl)methanesulfonatopalladium(II) dimer
|
812-498-4
|
1581285-85-9
|
|
Notified C&L
|
View details
|
TRICARBONYLTRIS(PROPIONITRILE)MOLYBDENUM (O)
|
812-500-3
|
103933-26-2
|
|
Notified C&L
|
View details
|
(R)-3-cyclohexyl-2-hydroxypropionic acid
|
812-501-9
|
156469-00-0
|
|
REACH registration C&L
|
View details
|
(R)-3-Cyclohexyl-2-hydroxypropionic acid benzyl ester
|
812-502-4
|
161313-45-7
|
|
Notified C&L
|
View details
|
methyl 4-(4-hydroxybutyl)benzoate
|
812-504-5
|
123910-88-3
|
|
Notified C&L
|
View details
|
Zinc bis[4-Methyl-5-imidazolecarboxaldehyde]
|
943-411-9
|
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
Iron(III) 1,3,5-benzenetricarboxylate hydrate
|
943-412-4
|
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
2,5-Furandione, telomer with ethylbenzene and (1-methylethyl)benzene, 2-methoxy-1-methylethyl 2-((2-methyl-1-oxo-2-propen-1-yl)oxy)ethyl ester
|
812-505-0
|
1889200-41-2
|
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L
|
View details
|
Waste plastics, poly(ethylene terephtalate), polymers with acrylic acid, adipic acid, dipropylene glycol and trimethylolpropane
|
812-506-6
|
1892578-66-3
|
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L
|
View details
|
tert-Butyl 4-hydrazinylpiperidine-1-carboxylate hydrochloride
|
812-507-1
|
1258001-18-1
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
reaction product of alumina and sulfuric acid
|
812-508-7
|
1093112-19-6
|
|
REACH registration C&L
|
View details
|
[No public or meaningful name is available]
|
812-509-2
|
3520-43-2
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 1
|
Notified C&L
|
View details
|
2-[5-[1-(5-Carboxypentyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-penta-1,3-dienyl]-1,3,3-trimethyl-3H-indolium bromide
|
812-510-8
|
666829-25-0
|
|
Notified C&L
|
View details
|
2-[5-[3-(5-Carboxypentyl)-1,3-dihydro-1,1-dimethyl-2H-benzo[e]indol-2-ylidene]-penta-1,3-dienyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt
|
812-511-3
|
210105-75-2
|
|
Notified C&L
|
View details
|
[5-[2-(3-Ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene]-4-oxo-2-thioxo-thiazolidin-3-yl]-acetic acid
|
812-512-9
|
34431-79-3
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-ethylidene]-1-cyclopenten-1-yl]-ethenyl]-1,3,3-trimethyl-3H-indolium 4-methylbenzenesulfonate
|
812-513-4
|
193687-61-5
|
|
Notified C&L
|
View details
|
Fats and Glyceridic oils, apricot kernel, ethoxylated
|
812-515-5
|
69071-70-1
|
|
Notified C&L
|
View details
|
3-Butyl-2-[3-(3-butyl-1,3-dihydro-1,1-dimethyl-2H-benzo[e]indol-2-ylidene)-propenyl]-1,1-dimethyl-1H-benzo[e]indolium perchlorate
|
812-516-0
|
189189-12-6
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(1,3-dihydro-1,1,3-trimethyl-2H-benzo[e]-indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,1,3-trimethyl-1H-benzo[e]indolium chloride
|
812-517-6
|
297173-98-9
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-ethylidene]-1-cyclopenten-1-yl]-ethenyl]-1,3,3-trimethyl-3H-indolium chloride
|
812-518-1
|
110992-55-7
|
|
Notified C&L
|
View details
|
Essential oil obtained from the fruits of Litsea cubeba (Lour.) Pers. by distillation
|
943-438-6
|
|
Asp. Tox. 1
Skin Irrit. 2
Skin Sens. 1B
Eye Irrit. 2
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
5-fluoro-1-[(4-methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine
|
812-520-2
|
1259279-57-6
|
|
Notified C&L
|
View details
|
(1R,2S,3S,4R)-3-((5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)bicyclo[2.2.2]octane-2-carboxylic acid
|
943-418-7
|
|
|
Notified C&L
|
View details
|
Benzenaminium, 3-amino-N,N,N-trimethylanilinium trichlorozincate
|
812-526-5
|
53831-80-4
|
Acute Tox. 3
Skin Sens. 1
Eye Irrit. 2
Acute Tox. 3
Carc. 1B
Aquatic Chronic 1
|
Notified C&L
|
View details
|
4-Chloro-2-nitropyridine
|
812-527-0
|
65370-42-5
|
|
Notified C&L
|
View details
|
(2-Bromophenyl)methanesulfonyl chloride
|
812-528-6
|
24974-74-1
|
|
Notified C&L
|
View details
|
1-Butyl-2-(5-(1-butyl-3,3-dimethyl-1,3-dihydro-indol-2-ylide ne)penta-1,3-dienyl)-3,3-dimethyl-3H-indolium perchlorate
|
812-529-1
|
131443-20-4
|
|
Notified C&L
|
View details
|
[4-[Bis-(4-dibutylamino-phenyl)-amino]-phenyl]-bis-(4-dibutylamino-phenyl)-ammonium hexafluorophosphate
|
812-530-7
|
152340-26-6
|
|
Notified C&L
|
View details
|
2-[5-[1-Carboxypentyl-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-penta-1,3-dienyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt
|
812-531-2
|
644979-16-8
|
|
Notified C&L
|
View details
|
1-Carboxypentyl-2-[5-[1-carboxypentyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-3-methyl-penta-1,3-dienyl]-3,3-dimethyl-5-sulfo-3H-indolium hydroxide, inner salt, sodium salt
|
812-532-8
|
367271-21-4
|
|
Notified C&L
|
View details
|
5,6-Dichloro-2-[3-[5,6-dichloro-1-octyl-3-(2-sulfopropyl)-benzimidazol-2-ylidene]-propenyl]-1-octyl-3-(2-sulfopropyl)-benzimidazolium hydroxide, inner salt, sodium salt
|
812-533-3
|
191032-02-7
|
|
Notified C&L
|
View details
|
5-Propyl-1,3,4-oxadiazol-2-amine
|
812-534-9
|
69741-89-5
|
|
Notified C&L
|
View details
|
3,3-Dimethyl-2-[2-[2-chloro-3-[2-[1,3-dihydro-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-5-sulfo-1-(4-sulfobutyl)-3H-indolium hydroxide, innersalt, trisodium salt
|
812-535-4
|
162093-39-2
|
|
Notified C&L
|
View details
|
2-[3-[1-Carboxypentyl-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-propenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt
|
812-537-5
|
644979-14-6
|
|
Notified C&L
|
View details
|
1,3-Dimethyl-5-[2-(3-methyl-thiazolidin-2-ylidene)-ethylidene]-pyrimidine-2,4,6-trione
|
812-538-0
|
428519-08-8
|
|
Notified C&L
|
View details
|
2-[3-[3,3-Dimethyl-1-(4-sulfobutyl)-1,3-dihydro-indol-2-ylidene]-propenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt
|
812-539-6
|
120724-84-7
|
|
Notified C&L
|
View details
|
methyl 5-methoxy-2-methylbenzoate
|
812-540-1
|
73502-03-1
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
|
|
|
|
|
|